Creating a well-known independent brand in China and telling the story of China's brand well is an important measure to promote the construction of "Quality China" and promote high-quality development. On the occasion of the 2025 "China Brand Day", as a representative of Chinese national pharmaceutical companies, Yiling Pharmaceutical actively responded to the "brand power" strategic call, guided by "China Brand·World Sharing", and jointly with hundreds of well-known pharmacies across the country, officially launched the "May 10 Yiling Brand Month" series of activities. The theme of this event is "Technology empowers health, brand leads the future". Through multi-dimensional innovations such as public welfare science popularization, chronic disease management, and digital services, it deepens industrial and commercial collaboration, helps improve the health literacy of the whole people, and contributes positive strength to the construction of a healthy China.

Focus on brand linkage to protect national health

Chronic disease prevention and control is the core issue of the Healthy China Action. During the "May 10 Yiling Brand Month" event, Yiling Pharmaceutical will join forces with tens of thousands of chain pharmacies in nearly 100 cities across the country to integrate high-quality medical resources, and bring consumers a comprehensive health service experience through the three-dimensional activity form of "online science popularization + offline services" to effectively meet consumers' health needs.

It is reported that this event takes the chain pharmacies as the service base, and through experts' online live science popularization and other forms, it helps chain members and consumers obtain professional health knowledge and improve the level of pharmacies' health services. At the same time, offline, hospital experts will work with hospital experts to simultaneously carry out activities such as screening of cardiovascular and cerebrovascular chronic diseases, free chronic disease diagnosis, etc., actively advocate the chronic disease management concept of "early screening, early diagnosis, and early intervention". Through a series of health science popularization activities, scientific drug use knowledge will be popularized, and chain pharmacies will work with chain pharmacies to provide consumers with more accurate health management services.

In addition, Yiling Pharmaceutical will cooperate in depth with well-known domestic chain pharmacies, gather advantageous resources such as academic brands and product brands, and carry out the "Care for the Health of the People and Help the Healthy China" public welfare and health science popularization roadshow activity across the country, so that more people can share a healthy life.

Innovation protects the quality of life to create trust

In recent years, Yiling Pharmaceutical has always insisted on revitalizing China's pharmaceutical brand, insisted on driving technological innovation, and systematically built a theoretical system for network diseases, becoming Yiling Pharmaceutical's unique core technological competitiveness. Focusing on the innovative research on the theory of network disease, Yiling Pharmaceutical has undertaken and completed a number of major scientific and technological innovation projects and won 6 national science and technology awards. The patented new drugs it has developed and launched on the market cover areas such as cardiovascular and cerebrovascular diseases, respiratory diseases, diabetes, and tumors, and have been recognized and praised by clinical experts and patients.

It is worth mentioning that the patented products such as Lianhua Qingwen Capsules and Tongxinluo Capsules produced by Yiling Pharmaceutical are not only widely recognized in the domestic market, but have also been approved for marketing in more than 50 countries and regions including Canada and Singapore, becoming a "business card" for traditional Chinese medicine to go global.

Practice social responsibility and interpret mission and responsibility

As a national key high-tech enterprise, Yiling Pharmaceutical has always adhered to the corporate purpose of "inheriting innovation and benefiting mankind", deepened social responsibility practice, and actively participated in the cause of social responsibility. In the field of green development, Yiling Pharmaceutical has achieved clean production and low-carbon energy through full-process emission reduction and resource recycling, with a water resource reuse rate of 97%. In terms of rural revitalization, it has built more than 60 high-standard Chinese medicinal materials bases, covering more than 20 provinces across the country, providing hundreds of thousands of jobs, and activates the rural industrial chain; in terms of social welfare, it has continued to promote universal medical care, ensure the supply of medical resources, and actively carried out public welfare activities related to people's health. From breakthroughs in scientific research to industrial development, from ecological protection to universal welfare of people's livelihood, Yiling Pharmaceutical uses its hard power in technology and a sense of social responsibility to interpret the responsibility of traditional Chinese medicine enterprises in multiple dimensions.

"May 10 Yiling Brand Month" is not only a concentrated display of Yiling Pharmaceutical's brand value, but also an innovative practice of industrial and commercial collaboration to serve the people's livelihood. In the future, enterprises will continue to use the dual-wheel drive of "drug + big health" to work with ecological partners to build a full-cycle service system from disease treatment to health management, jointly promote the construction of China's pharmaceutical brand, and contribute more to the realization of the goal of "Healthy China 2030". (Information)

(Text/Xu Lu)

[Editor in charge: Sun Hui]